Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury

Yulu Zhang,1,* Songyu Liu,1,* Jinyan Wan,1,* Qiyue Yang,2 Yan Xiang,1 Li Ni,1 Yu Long,1 Mingquan Cui,1 Zhimin Ci,1 Donglei Tang,1 Nan Li1 1College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, People’s Republic of China; 2Hospital of Chengdu University of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang Y, Liu S, Wan J, Yang Q, Xiang Y, Ni L, Long Y, Cui M, Ci Z, Tang D, Li N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	borneol-baicalin-liposome pharmacokinetics pharmacodynamics mcao Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8ab8988397f44513849a9b59fedf514f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8ab8988397f44513849a9b59fedf514f
record_format	dspace
spelling	oai:doaj.org-article:8ab8988397f44513849a9b59fedf514f2021-12-02T13:11:45ZPreparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury1178-2013https://doaj.org/article/8ab8988397f44513849a9b59fedf514f2020-08-01T00:00:00Zhttps://www.dovepress.com/preparation-characterization-and-in-vivo-study-of-borneol-baicalin-lip-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yulu Zhang,1,* Songyu Liu,1,* Jinyan Wan,1,* Qiyue Yang,2 Yan Xiang,1 Li Ni,1 Yu Long,1 Mingquan Cui,1 Zhimin Ci,1 Donglei Tang,1 Nan Li1 1College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, People’s Republic of China; 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Nan LiCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, No. 1166, Liutai Avenue, Chengdu 611137, People’s Republic of ChinaTel +86-28-61801001Email 55743198@qq.comPurpose: Baicalin (BA) has a good neuroprotective effect, but it is eliminated quickly in the body and does not easily reach the brain. In this experiment, borneol (BO) was used as an auxiliary drug to prepare borneol-baicalin-liposomes (BO-BA-LP) to prolong the efficacy time of BA, synergistically synergize, introduce drugs into the brain, and better exert the therapeutic effect on cerebral ischemia-reperfusion (I/R) injury.Methods: Through single-factor inspection and response surface optimization analysis, obtained the best preparation process of BO-BA-LP and characterized by various analytical techniques. Validated the long-term effectiveness of BA-BO-LP through pharmacokinetic studies and conducted pharmacodynamic studies on the middle cerebral artery occlusion (MCAO) rat model to verify the therapeutic effect of BO-BA-LP on cerebral I/R injury.Results: The optimum preparation conditions of BO-BA-LP were as follows: the dosage of BO was 9.55 mg, the ratio of phospholipid to drug was 4.02:1, the ratio of phospholipid to cholesterol was 7.25:1, the entrapment efficiency (EE) was 41.49%, and the drug loading (DL) was 4.29%. The particle size range of the liposomes was 167.1 nm, and the polydispersity index (PDI) range was 0.113. The results of pharmacokinetic experiments showed that the combination of BA and BO liposomes effectively improved the pharmacokinetic parameters of BA and prolonged the half-life of BA. Pharmacodynamic studies have found that, compared with BA-LP, BO-BA-LP can significantly improve neurological deficits, cerebral infarction volume, and brain pathological states on MCAO rats.Conclusion: These results demonstrated that BO-BA-LP can improve the circulation of drugs in the blood, and the addition of BO can enhance the therapeutic effect of BA and effectively improve cerebral I/R.Keywords: borneol-baicalin-liposome, pharmacokinetics, pharmacodynamics, MCAOZhang YLiu SWan JYang QXiang YNi LLong YCui MCi ZTang DLi NDove Medical Pressarticleborneol-baicalin-liposomepharmacokineticspharmacodynamicsmcaoMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 5977-5989 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	borneol-baicalin-liposome pharmacokinetics pharmacodynamics mcao Medicine (General) R5-920
spellingShingle	borneol-baicalin-liposome pharmacokinetics pharmacodynamics mcao Medicine (General) R5-920 Zhang Y Liu S Wan J Yang Q Xiang Y Ni L Long Y Cui M Ci Z Tang D Li N Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury
description	Yulu Zhang,1,* Songyu Liu,1,* Jinyan Wan,1,* Qiyue Yang,2 Yan Xiang,1 Li Ni,1 Yu Long,1 Mingquan Cui,1 Zhimin Ci,1 Donglei Tang,1 Nan Li1 1College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, People’s Republic of China; 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Nan LiCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, No. 1166, Liutai Avenue, Chengdu 611137, People’s Republic of ChinaTel +86-28-61801001Email 55743198@qq.comPurpose: Baicalin (BA) has a good neuroprotective effect, but it is eliminated quickly in the body and does not easily reach the brain. In this experiment, borneol (BO) was used as an auxiliary drug to prepare borneol-baicalin-liposomes (BO-BA-LP) to prolong the efficacy time of BA, synergistically synergize, introduce drugs into the brain, and better exert the therapeutic effect on cerebral ischemia-reperfusion (I/R) injury.Methods: Through single-factor inspection and response surface optimization analysis, obtained the best preparation process of BO-BA-LP and characterized by various analytical techniques. Validated the long-term effectiveness of BA-BO-LP through pharmacokinetic studies and conducted pharmacodynamic studies on the middle cerebral artery occlusion (MCAO) rat model to verify the therapeutic effect of BO-BA-LP on cerebral I/R injury.Results: The optimum preparation conditions of BO-BA-LP were as follows: the dosage of BO was 9.55 mg, the ratio of phospholipid to drug was 4.02:1, the ratio of phospholipid to cholesterol was 7.25:1, the entrapment efficiency (EE) was 41.49%, and the drug loading (DL) was 4.29%. The particle size range of the liposomes was 167.1 nm, and the polydispersity index (PDI) range was 0.113. The results of pharmacokinetic experiments showed that the combination of BA and BO liposomes effectively improved the pharmacokinetic parameters of BA and prolonged the half-life of BA. Pharmacodynamic studies have found that, compared with BA-LP, BO-BA-LP can significantly improve neurological deficits, cerebral infarction volume, and brain pathological states on MCAO rats.Conclusion: These results demonstrated that BO-BA-LP can improve the circulation of drugs in the blood, and the addition of BO can enhance the therapeutic effect of BA and effectively improve cerebral I/R.Keywords: borneol-baicalin-liposome, pharmacokinetics, pharmacodynamics, MCAO
format	article
author	Zhang Y Liu S Wan J Yang Q Xiang Y Ni L Long Y Cui M Ci Z Tang D Li N
author_facet	Zhang Y Liu S Wan J Yang Q Xiang Y Ni L Long Y Cui M Ci Z Tang D Li N
author_sort	Zhang Y
title	Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury
title_short	Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury
title_full	Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury
title_fullStr	Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury
title_full_unstemmed	Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury
title_sort	preparation, characterization and in vivo study of borneol-baicalin-liposomes for treatment of cerebral ischemia-reperfusion injury
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/8ab8988397f44513849a9b59fedf514f
work_keys_str_mv	AT zhangy preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT lius preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT wanj preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT yangq preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT xiangy preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT nil preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT longy preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT cuim preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT ciz preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT tangd preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury AT lin preparationcharacterizationandinvivostudyofborneolbaicalinliposomesfortreatmentofcerebralischemiareperfusioninjury
_version_	1718393458763235328

Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury

Ejemplares similares